Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bukreyev

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Journal of Virology|September 15, 2007
Virally delivered cytokines alter the immune response to future lung infectionsJames Harker, Alexander Bukreyev, Peter L Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Alexander Bukreyev, Mario H Skiadopoulos, Josephine McAuliffe, et al.
Research Square|May 3, 2023
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement systemAlexander Bukreyev, Philipp Ilinykh, Kai Huang, et al.
Vaccine|November 2, 2010
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody responseJoshua M DiNapoli, Lijuan Yang, Siba K Samal, et al.
Journal of Virology|October 10, 2008
The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytesAlexander Bukreyev, Lijuan Yang, Jens Fricke, et al.
Plos Pathogens|December 9, 2016
The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune ResponsesNdongala Michel Lubaki, Patrick Younan, Rodrigo I Santos, et al.
Journal of Virology|April 26, 2013
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domainsNdongala M Lubaki, Philipp Ilinykh, Colette Pietzsch, et al.
Mbio|October 9, 2025
Distinct immune properties of the N- and C-termini of the immunosuppressive domain of Ebola virus glycoproteinMathieu Iampietro, Sivakumar Periasamy, Philipp A Ilinykh, et al.
Journal of Virology|December 20, 2019
Ebola Virus Produces Discrete Small Noncoding RNAs Independently of the Host MicroRNA Pathway Which Lack RNA Interference Activity in Bat and Human CellsAbhishek N Prasad, Adam J Ronk, Steven G Widen, et al.
Plos Pathogens|May 3, 2011
Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte responseShirin Munir, Philippa Hillyer, Cyril Le Nouën, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Journal of Virology|September 15, 2007
Virally delivered cytokines alter the immune response to future lung infectionsJames Harker, Alexander Bukreyev, Peter L Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Alexander Bukreyev, Mario H Skiadopoulos, Josephine McAuliffe, et al.
Research Square|May 3, 2023
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement systemAlexander Bukreyev, Philipp Ilinykh, Kai Huang, et al.
Vaccine|November 2, 2010
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody responseJoshua M DiNapoli, Lijuan Yang, Siba K Samal, et al.
Journal of Virology|October 10, 2008
The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytesAlexander Bukreyev, Lijuan Yang, Jens Fricke, et al.
Plos Pathogens|December 9, 2016
The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune ResponsesNdongala Michel Lubaki, Patrick Younan, Rodrigo I Santos, et al.
Journal of Virology|April 26, 2013
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domainsNdongala M Lubaki, Philipp Ilinykh, Colette Pietzsch, et al.
Mbio|October 9, 2025
Distinct immune properties of the N- and C-termini of the immunosuppressive domain of Ebola virus glycoproteinMathieu Iampietro, Sivakumar Periasamy, Philipp A Ilinykh, et al.
Journal of Virology|December 20, 2019
Ebola Virus Produces Discrete Small Noncoding RNAs Independently of the Host MicroRNA Pathway Which Lack RNA Interference Activity in Bat and Human CellsAbhishek N Prasad, Adam J Ronk, Steven G Widen, et al.
Plos Pathogens|May 3, 2011
Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte responseShirin Munir, Philippa Hillyer, Cyril Le Nouën, et al.
Pageof 17